Crititech, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Crititech, Inc.
Quantité totale PI 74
Rang # Quantité totale PI 19 008
Note d'activité PI 2,5/5.0    34
Rang # Activité PI 22 886
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

43 1
4 0
26 0
0
 
Dernier brevet 2025 - Cisplatin particles and uses the...
Premier brevet 2002 - Compositions and methods for del...
Dernière marque 2004 - NANOTAX
Première marque 2004 - NANOTAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Cisplatin particles and uses thereof. Compositions of particles having at least 95% by weight of...
2024 Invention Taxane particles and their use. Compositions are provided that include having at least 95% by we...
Invention Glucocorticoid particles and their use. Disclosed herein are particles of at least 95% by weight...
Invention Local delivery of antineoplastic particles in combination with systemic delivery of immunotherape...
2023 Invention Cisplatin particles and uses thereof. Suspensions and their use for treating tumors are provided...
Invention Cisplatin particles and uses thereof. Suspensions and their use for treating tumors are provided,...
Invention Sorafenib particles and uses thereof. Particles of at least 95% by weight of sorafenib, or a pha...
Invention Treatment of epithelial cysts by intracystic injection of antineoplastic particles. Disclosed her...
2022 Invention Niraparib particles and uses thereof. Compositions of particles having at least 95% by weight of ...
Invention Rucaparib particles and uses thereof. Compositions of particles having at least 95% by weight of ...
Invention Rucaparib particles and uses thereof. 2/g, methods for their use, and methods for their productio...
Invention Niraparib particles and uses thereof. 2/g, methods for their use, and methods for their productio...
Invention Methods for solid tumor treatment. Disclosed herein are methods for treating solid tumors by dire...
Invention Lapatinib particles and uses thereof. 2/g and have a mean particle size by volume distribution of...
Invention Cisplatin particles and uses thereof. Compositions of particles having at least 95% by weight of ...
2021 Invention Treatment of bladder cancer by local administration of taxane particles. Disclosed herein are me...
Invention Niclosamide particles and uses thereof. The disclosure provides compositions and methods for use...
Invention Niclosamide particles and uses thereof. The disclosure provides compositions and methods for use ...
Invention Ciprofloxacin polymorph and its use. The present disclosure relates to ciprofloxacin polymorphs ...
Invention Sorafenib particles and uses thereof. The disclosure provides particles of at least 95% by weigh...
Invention Sorafenib particles and uses thereof. A composition comprising particles of at least 95% by weigh...
Invention Lapatinib particles and uses thereof. The disclosure provides particles of at least 95% by weigh...
Invention Lapatinib particles and uses thereof. The disclosure provides particles of at least 95% by weight...
2020 Invention Taxane particles and their use. 2/g. Methods for making and using such compositions are also prov...
2019 Invention Methods for treating lung disorders. Disclosed herein are compositions and methods for treating l...
Invention Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and ca...
Invention Use of antineoplastic agents to stimulate the immune system for production of tertiary lymphoid s...
Invention Use of antineoplastic agents to stimulate the immune system for treatment of cancer. Disclosed a...
Invention Treatment of kidney tumors by intratumoral injection of taxane particles. Disclosed herein are c...
Invention Treatment of kidney tumors by intratumoral injection of taxane particles. Disclosed herein are co...
2018 Invention Glucocorticoid “nintedanib” particles and their use. 2/g, methods for making such particles, and ...
Invention Ciprofloxacin polymorph and its use. The present disclosure relates to ciprofloxacin polymorphs a...
2004 P/S PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, AND FOR THERAPEUTIC COATINGS FOR IMPLANT...